TriSalus Life Sciences Names Richard Marshall, MD, Chief Medical Officer TriSalus Life Sciences, a clinical-stage oncology company focused on integrating innovative drug delivery technologies with standard-of-care therapies and immunotherapeutic approaches,…
Amy Koch Joins Propel Health Medical Affairs as Senior Vice President, Client Services Propel Health Medical Affairs (PHMA), a full-service scientific communications agency operating within the broader Propel Health ecosystem,…
Endospan Secures U.S. Food and Drug Administration Approval for NEXUS® Aortic Arch Stent Graft System Endospan, a privately held innovator focused on advancing endovascular therapies for complex aortic conditions, has…
GenSight Biologics Provides Update on Cash Position and Early Access Program Revenue as of March 31, 2026 GenSight Biologics, a clinical-stage biopharmaceutical company dedicated to the development and commercialization of…
Stoke Therapeutics Announces Appointment of Dr. Clare Kahn to Its Board of Directors Stoke Therapeutics, a clinical-stage biotechnology company focused on restoring protein expression through RNA-based medicines, has announced the…
Amgen Shares Positive Topline Phase 3 Data for Subcutaneous TEPEZZA® in Adults with Moderate-to-Severe Active Thyroid Eye Disease Amgen (NASDAQ: AMGN) has announced positive topline results from a pivotal Phase…
CareQuest Institute Appoints An Nguyen, DDS, MPH, to Serve as Chief Clinical Officer CareQuest Institute for Oral Health has announced the appointment of An Nguyen, DDS, MPH, as its new…
Alcon Introduces Clareon TruPlus Monofocal and Toric IOLs Featuring Advanced Design Innovations at ASCRS 2026 Alcon a global leader in eye care committed to advancing vision health and improving patient…
ZIVO Bioscience Enters Large-Scale Manufacturing Partnership with Cyanotech Corporation to Produce Zivolife™ Algal Biomass Zivo Bioscience, Inc. (OTCQB: ZIVO), a research-driven biotech and agtech innovator specializing in therapeutic, medicinal, and…
Frazier Life Sciences brings on Christian Schade as Senior Advisor to strengthen strategic expertise Frazier Life Sciences (FLS), a well-established investment firm dedicated to advancing innovative biopharmaceutical companies, has announced…
Affinia Therapeutics Secures Health Canada Clearance to Launch UPBEAT© Phase 1/2 Trial Evaluating AFTX-201 for BAG3-Related Dilated Cardiomyopathy Affinia Therapeutics, a clinical-stage biotechnology company focused on advancing next-generation gene therapies…
Bridge Dental Group Strengthens Its Growing Network by Adding Foothill Family Dental Group and Peak Dental Specialists Bridge Dental Group has announced a significant expansion of its footprint in the…